Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BRIACELL THERAP (BCTX) vs Karyopharm Therapeutics Inc. (KPTI)

BRIACELL THERAP and Karyopharm Therapeutics Inc. are both Biotechnology companies. BRIACELL THERAP and Karyopharm Therapeutics Inc. are of similar size ($39.2M and $37.2M). Karyopharm Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; BRIACELL THERAP trades at 1.9×. BRIACELL THERAP has the higher net margin (0.00% vs −153.3%) and the lower return on invested capital (−3,311.0% vs 0.00%). Across the 13 metrics below, BRIACELL THERAP leads on 8 and Karyopharm Therapeutics Inc. on 5.

Valuation

Metric BCTX KPTI Biotechnology median
P/E 1.94 n/m 7.88
P/S n/m 0.32 11.47
P/B 1.34 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 1.58 10.73
Earnings yield 51.65% (874.99%) (28.84%)
Free cash flow yield (100.28%) (139.70%) (23.03%)

Profitability

Metric BCTX KPTI Biotechnology median
Gross margin 0.00% 95.89% 65.16%
Operating margin 0.00% (56.17%) 0.00%
Net margin 0.00% (153.28%) 0.00%
Free cash flow margin 0.00% (44.57%) 0.00%
Return on equity (173.55%) 78.98% (57.72%)
Return on assets (139.20%) (207.90%) (49.22%)
Return on invested capital (3,311.00%) 0.00% 0.00%

Growth

Metric BCTX KPTI Biotechnology median
Revenue growth (TTM) — 6.81% 5.64%
EPS growth (last fiscal year) (43.04%) (98.37%) —
Revenue growth, 5-year CAGR — 6.21% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCTX KPTI Biotechnology median
Debt to equity 0.00 (0.76) 0.00
Current ratio 7.07 0.79 4.73
Net debt to EBITDA 0.66 (2.03) 0.96

Dividend

Metric BCTX KPTI Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BCTX KPTI Biotechnology median
Market cap 37.24m 39.24m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack